You are here

  • Home
  • Archive
  • Volume 12, Issue 5
  • Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy

Article info

Article menu
Basic tumor immunology
Original research
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy

Authors

  • Kevin Chih-Yang Huang Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, TaiwanTranslation Research Core, China Medical University Hospital, Taichung, TaiwanCancer Biology and Precision Therapeutics Center, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Shu-Fen Chiang Lab of Precision Medicine, Feng-Yuan Hospital Ministry of Health and Welfare, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Hsin-Yu Chang Translation Research Core, China Medical University Hospital, Taichung, TaiwanProton Cancer, China Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Wei-Ze Hong Proton Cancer, China Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Jhen-Yu Chen Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, TaiwanTranslation Research Core, China Medical University Hospital, Taichung, TaiwanProton Cancer, China Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Pei-Chih Lee Cancer Biology and Precision Therapeutics Center, China Medical University, Taichung, TaiwanGraduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Ji-An Liang Department of Radiation Oncology, China Medical University Hospital, Taichung, TaiwanSchool of Medicine, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Tao-Wei Ke Department of Colorectal Cancer, China Medical University Hospital, Taichung, TaiwanSchool of Chinese Medicine, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Shin-Lei Peng Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • An‑Cheng Shiau Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, TaiwanProton Cancer, China Medical University Hospital, Taichung, TaiwanDepartment of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Tsung-Wei Chen Department of Pathology, Asia University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Pei-Chen Yang Proton Cancer, China Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • William Tzu-Liang Chen School of Medicine, China Medical University, Taichung, TaiwanDepartment of Colorectal Cancer, China Medical University Hospital, Taichung, TaiwanDepartment of Colorectal Surgery, China Medical University HsinChu Hospital, China Medical University Hospital, HsinChu, Taiwan PubMed articlesGoogle scholar articles
  • K S Clifford Chao Proton Cancer, China Medical University Hospital, Taichung, TaiwanDepartment of Radiation Oncology, China Medical University Hospital, Taichung, TaiwanSchool of Medicine, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles

Citation

Huang KC, Chiang S, Chang H, et al
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy
Journal for ImmunoTherapy of Cancer 2024;12:e008515. doi: 10.1136/jitc-2023-008515
Online issue publication 
May 15, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.